These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 32534077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
    Ijiro T, Yaguchi A, Yokoyama A, Kiguchi S.
    Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):950-958. PubMed ID: 35637550
    [Abstract] [Full Text] [Related]

  • 3. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
    Ijiro T, Nakamura K, Ogata M, Inada H, Kiguchi S, Maruyama K, Nabekura J, Kobayashi M, Ishibashi H.
    Eur J Pharmacol; 2015 Aug 15; 761():413-22. PubMed ID: 26142830
    [Abstract] [Full Text] [Related]

  • 4. Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.
    Nakamura T, Honda M, Kimura S, Tanabe M, Oda S, Ono H.
    Biol Pharm Bull; 2005 Dec 15; 28(12):2244-7. PubMed ID: 16327158
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
    Nakayama T, Nagai Y.
    Jpn J Pharmacol; 1996 Nov 15; 72(3):241-6. PubMed ID: 8957685
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue.
    Kobayashi K, Abe Y, Harada H, Oota E, Endo T, Takeda H.
    Xenobiotica; 2019 Jan 15; 49(1):106-119. PubMed ID: 29300135
    [Abstract] [Full Text] [Related]

  • 9. Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.
    Kinoshita K, Fukushima T, Kodama Y, Sugihara J, Yamamura M, Matsuoka Y.
    Biol Pharm Bull; 1997 Jan 15; 20(1):36-9. PubMed ID: 9013803
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
    Matsui K, Toyoshima E, Mano U, Ando K.
    Yakubutsu Seishin Kodo; 1982 Dec 15; 2(2):77-80. PubMed ID: 6821292
    [Abstract] [Full Text] [Related]

  • 15. Thyrotropin-releasing hormone (TRH) in the cerebellum.
    Shibusawa N, Hashimoto K, Yamada M.
    Cerebellum; 2008 Dec 15; 7(1):84-95. PubMed ID: 18418668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of in vivo anti-hypothermic effect of all stereoisomers of the thyrotropin-releasing hormone mimetic: Rovatirelin Hydrate.
    Kobayashi N, Sato N, Sugita K, Takahashi K, Sugawara T, Tada Y, Yoshikawa T.
    J Pept Sci; 2019 Dec 15; 25(12):e3228. PubMed ID: 31713944
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.